BioNTech SE is 18.3x more valuable than Immatics N.V. by market capitalization ($21.79 B vs $1.19 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IMTX | BNTX |
|---|---|---|
| Market cap | $1.19 B | $21.79 B |
| US-listed rank | #2508 | #587 |
| SEC filings | 220 | 548 |
BioNTech SE is 18.3x more valuable than Immatics N.V. by market capitalization ($21.79 B vs $1.19 B).
Full pages: Immatics N.V. and BioNTech SE, or browse the full rankings.